LONDON, Dec 11 () - Danish biotech Zealand Pharma said on Thursday it will ​accelerate development and expand its research ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Target expands protein and supplement offerings as appetite-suppressing weight-loss drugs change consumer habits.

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Elon Musk's rocket company is reportedly aiming to go public at a $1.5 trillion valuation, which would set a new IPO record.

The obesity treatment space has been generating plenty of headlines – and sales – over the past few years. GLP-1 receptor ...

Pfizer PFE announced that it is in-licensing exclusive global rights to develop, manufacture and commercialize YP05002, an ...

Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...

Pharma companies need to move beyond the “weight-loss Olympics” and focus on more durable treatments with fewer side effects, ...

By Nancy Lapid Dec 10 (Reuters) - A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces ...

Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company's next-generation obesity pill. The move signals Lilly's aggressive expansion ...